AC Immune SA-Product Pipeline Review-2015

AC Immune SA-Product Pipeline Review-2015

  • Products Id :- GMDHC06973CDB
  • |
  • Pages: 29
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

AC Immune SA-Product Pipeline Review-2015


Global Markets Direct's, 'AC Immune SA-Product Pipeline Review-2015', provides an overview of the AC Immune SA's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of AC Immune SA's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


The report provides brief overview of AC Immune SA including business description, key information and facts, and its locations and subsidiaries

The report reviews current pipeline of AC Immune SA's human therapeutic division and enlists all their major and minor projects

The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones

Special feature on out-licensed and partnered product portfolio

The report summarizes all the dormant and discontinued pipeline projects

Latest company statement

Latest news and deals relating to the AC Immune SA's pipeline products

Reasons To Buy

Evaluate AC Immune SA's strategic position with total access to detailed information on its product pipeline

Assess the growth potential of AC Immune SA in its therapy areas of focus

Identify new drug targets and therapeutic classes in the AC Immune SA's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas

Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps

Develop strategic initiatives by understanding the focus areas of AC Immune SA and exploit collaboration and partnership opportunities

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Plan mergers and acquisitions effectively by identifying the most promising pipeline of AC Immune SA

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Explore the dormant and discontinued projects of AC Immune SA and identify potential opportunities in those areas

Avoid Intellectual Property Rights related issues

Read More

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications


Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

AC Immune SA Snapshot 5

AC Immune SA Overview 5

Key Information 5

Key Facts 5

AC Immune SA-Research and Development Overview 6

Key Therapeutic Areas 6

AC Immune SA-Pipeline Review 8

Pipeline Products by Stage of Development 8

Pipeline Products-Monotherapy 9

Pipeline Products-Out-Licensed Products 10

Out-Licensed Products/Combination Treatment Modalities 11

AC Immune SA-Pipeline Products Glance 12

AC Immune SA-Clinical Stage Pipeline Products 12

Phase I Products/Combination Treatment Modalities 12

AC Immune SA-Early Stage Pipeline Products 13

Preclinical Products/Combination Treatment Modalities 13

AC Immune SA-Drug Profiles 14

ACI-24 14

Product Description 14

Mechanism of Action 14

R&D Progress 14

ACI-35 15

Product Description 15

Mechanism of Action 15

R&D Progress 15

ACI-260 16

Product Description 16

Mechanism of Action 16

R&D Progress 16

ACI-812 17

Product Description 17

Mechanism of Action 17

R&D Progress 17

Small Molecule to Inhibit Alpha-Synuclein for Parkinson's Disease 18

Product Description 18

Mechanism of Action 18

R&D Progress 18

Small Molecule to Inhibit Tau Protein for Alzheimer's Disease 19

Product Description 19

Mechanism of Action 19

R&D Progress 19

AC Immune SA-Pipeline Analysis 20

AC Immune SA-Pipeline Products by Target 20

AC Immune SA-Pipeline Products by Route of Administration 21

AC Immune SA-Pipeline Products by Molecule Type 22

AC Immune SA-Pipeline Products by Mechanism of Action 23

AC Immune SA-Recent Pipeline Updates 24

AC Immune SA-Dormant Projects 25

AC Immune SA-Discontinued Pipeline Products 26

Discontinued Pipeline Product Profiles 26

pirenzepine 26

AC Immune SA-Locations And Subsidiaries 27

Head Office 27

Appendix 28

Methodology 28

Coverage 28

Secondary Research 28

Primary Research 28

Expert Panel Validation 28

Contact Us 28

Disclaimer 29

List of Tables

AC Immune SA, Key Information 5

AC Immune SA, Key Facts 5

AC Immune SA-Pipeline by Indication, 2015 7

AC Immune SA-Pipeline by Stage of Development, 2015 8

AC Immune SA-Monotherapy Products in Pipeline, 2015 9

AC Immune SA-Out-Licensed Products in Pipeline, 2015 10

AC Immune SA-Out-Licensed Products/ Combination Treatment Modalities, 2015 11

AC Immune SA-Phase I, 2015 12

AC Immune SA-Preclinical, 2015 13

AC Immune SA-Pipeline by Target, 2015 20

AC Immune SA-Pipeline by Route of Administration, 2015 21

AC Immune SA-Pipeline by Molecule Type, 2015 22

AC Immune SA-Pipeline Products by Mechanism of Action, 2015 23

AC Immune SA-Recent Pipeline Updates, 2015 24

AC Immune SA-Dormant Developmental Projects,2015 25

AC Immune SA-Discontinued Pipeline Products, 2015 26

List of Figures

AC Immune SA-Pipeline by Top 10 Indication, 2015 7

AC Immune SA-Pipeline by Stage of Development, 2015 8

AC Immune SA-Monotherapy Products in Pipeline, 2015 9

AC Immune SA-Out-Licensed Products in Pipeline, 2015 10

AC Immune SA-Pipeline by Top 10 Target, 2015 20

AC Immune SA-Pipeline by Top 10 Route of Administration, 2015 21

AC Immune SA-Pipeline by Top 10 Molecule Type, 2015 22

AC Immune SA-Pipeline Products by Top 10 Mechanism of Action, 2015 23

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@]

Current R&D Portfolio of AC Immune SA; AC Immune SA - Key Therapeutics; AC Immune SA - Pipeline Overview and Promising Molecules; AC Immune SA - News; AC Immune SA - Latest Updates; AC Immune SA - Pipeline; AC Immune SA - Discontinued/Dormant Projects

select a license

Single User License
USD 1500 INR 95910
Site License
USD 3000 INR 191820
Corporate User License
USD 4500 INR 287730



The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...

Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India


Company Brochure

Engage with Us

query [@]